Sponsors (12)
The bill strengthens national security by limiting foreign access to sensitive synthetic genetic designs and creates a clearer rulemaking deadline, but does so at the cost of added compliance, potential delays to research collaborations, and administrative uncertainty for researchers, startups, and small firms.
Scientists, biotech firms, and the public: Stricter export controls on synthetic DNA/RNA and bio-design data reduce the risk that hostile foreign governments or actors (including state adversaries) obtain or misuse sensitive genetic designs and dual‑use technologies.
Researchers and companies that hold proprietary designs: Tighter controls make it harder for foreign adversaries to steal or exfiltrate proprietary sequence designs and IP, helping protect competitive advantage and investments in sensitive biotech R&D.
Researchers and regulated entities: The bill creates a clear legal mandate and one‑year deadline for Commerce to set rules (and exempts information already covered by existing public‑information rules), improving regulatory predictability and helping avoid needless duplication.
Academic labs, biotech companies, and startups: New export controls, licensing requirements, and compliance processes will increase costs and slow cross‑border research collaboration and data sharing (including delays in exporting sequence files), harming productivity and timelines for R&D.
Researchers, students, and international collaborators: Restrictions and licensing burdens could hinder international scientific collaboration and slow legitimate biomedical innovation and training partnerships.
Small firms, government agencies, and taxpayers: Tighter export rules will create additional administrative burdens and compliance costs for companies and government, which may be passed on to taxpayers or divert resources from other priorities.
Based on analysis of 3 sections of legislative text.
Adds an export‑license requirement for transfers to foreign entities of digital files encoding human‑ or AI‑designed synthetic DNA/RNA sequences.
Introduced December 11, 2025 by Warren Davidson · Last progress December 11, 2025
Requires federal export controls on digital files that encode synthetic DNA or RNA sequences when transferred to certain foreign governments, entities, or persons deemed “of concern,” with the Secretary required to put the licensing rule in place within one year. Defines covered material (including AI‑designed sequences and several forms of synthetic nucleic acids), specifies who counts as a foreign entity of concern, and excludes material already exempted under 15 C.F.R. § 734.3(b).